Surgical results and surgical adjuvant therapy for lung cancer

Careful intraoperative surgical staging should be considered routine for all patients undergoing thoracotomy for lung cancer. In addition, conservative resection is indicated for T1N0 lesions. Surgical adjuvant immunotherapy has not proved as effective as originally hoped. However, the advent of more effective combination chemotherapy for advanced lung cancer has led to the evolution of these agents as adjuncts to surgery. The preliminary results are promising.